Navigation Links
Janssen and Johnson & Johnson to Provide Webcast Presentation on the Janssen Oncology Hematologic Malignancy Portfolio
Date:1/15/2016

NEW BRUNSWICK, N.J., Jan. 15, 2016 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) and Johnson & Johnson (NYSE: JNJ) will provide a pre-recorded webcast focused on data from the Janssen Oncology hematologic malignancy portfolio for investors and other interested parties on Friday, January 15.

The pre-recorded webcast features Peter F. Lebowitz, MD, PhD, Global Therapeutic Area Head of Oncology for Janssen R&D, recapping key data presentations on DARZALEX™ (daratumumab) and IMBRUVICA® (ibrutinib) that were featured at the 2015 American Society of Hematology (ASH) Annual meeting. Dr. Lebowitz will also describe the development plans for these and other compounds in the Janssen Oncology hematologic malignancy portfolio.

The webcast/podcast can be accessed by visiting the Johnson & Johnson website at www.investor.jnj.com and clicking on "Webcasts/Presentations." The webcast duration is approximately 18 minutes and will be available through the end of February.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. WuXi AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement
2. ViiV Healthcare to Progress Collaboration with Janssen to Develop the First Long-acting, Two Drug Injectable Regimen for Treatment of HIV-1 Infection
3. Janssen Announces Collaboration with Bavarian Nordic to Develop Vaccine for Chronic Human Papillomavirus (HPV) Infections
4. Janssen to Showcase Growing Portfolio with More Than 40 Data Presentations at the 2015 American Society of Hematology (ASH) Annual Meeting
5. Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
6. Leitender Neurowissenschaftler bei Janssen in den Wissenschaftlichen Beirat des globalen Dementia Discovery Fund bestellt
7. Janssen Tackles Mental Health Stigma in New Healthy Minds Videos
8. U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma
9. New Study by TSRI and Janssen Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine
10. Black Celebrities Come Out to Honor 2015 Heroes in the Struggle Honoring Jussie Smollett, Gregorio Millett, Vanessa Mills, and Janssen Therapeutics
11. Janssen Initiates Rolling Submission of Biologic License Application (BLA) for daratumumab with U.S. FDA for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2019)... CYPRESS, Calif. (PRWEB) , ... March 25, 2019 ... ... Leandra Hernández , along with Dr. Jennifer Belding, served as co-editors on the ... published through Lexington Press . , With contributors from fields including ...
(Date:3/23/2019)... ... , ... Atkinson Ergonomic Solutions, Inc. has entered the hospitality market with a ... a housekeeper to safely and single-handedly raise the heaviest beds with ease. The ... and away from the wall are many. The bed will stay in the raised ...
(Date:3/20/2019)... ... March 20, 2019 , ... Developing PVC Free Medical ... has woken up to realize the hidden health hazards associated with PVC-based medical ... toxic effects and perilous health problems that affect the functioning of the human ...
Breaking Medicine Technology:
(Date:3/20/2019)... ... March 20, 2019 , ... ... being developed with Wi-Fi connectivity to allow portable devices to be easily moved ... monitoring, glucose monitoring, and other wearable devices for home healthcare require “always on” ...
(Date:3/20/2019)... , ... March 20, 2019 , ... GRM Information Management, ... Information Management Systems Society (HIMSS) conference in Austin, Texas on March 25 and 26. ... to learn more about GRM’s healthcare information management solutions . , GRM offers ...
(Date:3/20/2019)... IPSWICH, Mass. (PRWEB) , ... March 20, 2019 ... ... evidence-based clinical resources including Option Grid™ decision aids, has announced the ... Test for Chromosome Problems: Yes or No? and Down Syndrome Screening Test: Yes ...
(Date:3/20/2019)... ... March 20, 2019 , ... Dr. Joe Lowrance, psychologist ... for financial consultants: “Learn to practice mindfulness.” , In a white paper, ... Dr. Lowrance writes that financial advisors are discovering the power of mindfulness as ...
(Date:3/20/2019)... ... March 20, 2019 , ... VirtuOx, ... a new way to diagnose cardiac arrhythmias in the patient’s home. , The ... by utilizing mobile cardiac telemetry (MCT) in the convenience and comfort of the ...
Breaking Medicine News(10 mins):